It's How Medicine Should Be®

Physician Profile

-or-

call (888) 352-RUSH for help arranging an appointment

Photo Not Available

Julie Schneider, MD, MS

Specialty:
  • Neurology
  • Neuropathology
Board Certification:
  • Neurology
  • Neuropathology
Faculty Rank: Associate Professor
Medical or Graduate Education: University of Illinois College of Medicine at Chicago
Residency: University of Chicago Medical Center - Neurology
Fellowship: University of Chicago Medical Center - Neuropathology
Clinical Expertise:
  • Alzheimer's disease
  • Dementia
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.

  1. A novel GRN mutation (GRN c.708+6_+9delTGAG) in frontotemporal lobar degeneration with TDP-43-positive inclusions: clinicopathologic report of 6 cases.
    Bit-Ivan EN, Suh E, Shim HS, Weintraub S, Hyman BT, Arnold SE, McCarty-Wood E, Van Deerlin VM, Schneider JA, Trojanowski JQ, Frosch MP, Baker MC, Rademakers R, Mesulam M, Bigio EH
    J. Neuropathol. Exp. Neurol.
    2014 May
    73(5):467-73.
  2. Reply to Itzhaki and Klapper.
    Lurain NS, Hanson BA, Martinson J, Leurgans SE, Landay AL, Bennett DA, Schneider JA
    J. Infect. Dis.
    2014 Mar
    209(6):974.
  3. Harm avoidance and cerebral infarction.
    Wilson RS, Boyle PA, Levine SR, Yu L, Hoganson GM, Buchman AS, Schneider JA, Bennett DA
    Neuropsychology
    2014 Mar
    28(2):305-11.
  4. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.
    Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ, Frosch MP, Alafuzoff I, Antonell A, Bogdanovic N, Brooks W, Cairns NJ, Cooper-Knock J, Cotman C, Cras P, Cruts M, De Deyn PP, DeCarli C, Dobson-Stone C, Engelborghs S, Fox N, Galasko D, Gearing M, Gijselinck I, Grafman J, Hartikainen P, Hatanpaa KJ, Highley JR, Hodges J, Hulette C, Ince PG, Jin LW, Kirby J, Kofler J, Kril J, Kwok JB, Levey A, Lieberman A, Llado A, Martin JJ, Masliah E, McDermott CJ, McKee A, McLean C, Mead S, Miller CA, Miller J, Munoz DG, Murrell J, Paulson H, Piguet O, Rossor M, Sanchez-Valle R, Sano M, Schneider J, Silbert LC, Spina S, van der Zee J, Van Langenhove T, Warren J, Wharton SB, White CL, Woltjer RL, Trojanowski JQ, Lee VM, Van Deerlin V, Chen-Plotkin AS
    Acta Neuropathol.
    2014 Mar
    127(3):407-18.
  5. Positive Florbetapir PET Amyloid Imaging in a Subject with Frequent Cortical Neuritic Plaques and Frontotemporal Lobar Degeneration with TDP43-Positive Inclusions.
    Serrano GE, Sabbagh MN, Sue LI, Hidalgo JA, Schneider JA, Bedell BJ, Van Deerlin VM, Suh E, Akiyama H, Joshi AD, Pontecorvo MJ, Mintun MA, Beach TG
    J. Alzheimers Dis.
    2014 Jun 13
  6. Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? - Authors' reply.
    Greenberg SM, Al-Shahi Salman R, Biessels GJ, van Buchem M, Cordonnier C, Lee JM, Montaner J, Schneider JA, Smith EE, Vernooij M, Werring DJ
    Lancet Neurol
    2014 Jun
    13(6):540.
  7. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.
    Nelson PT, Estus S, Abner EL, Parikh I, Malik M, Neltner JH, Ighodaro E, Wang WX, Wilfred BR, Wang LS, Kukull WA, Nandakumar K, Farman ML, Poon WW, Corrada MM, Kawas CH, Cribbs DH, Bennett DA, Schneider JA, Larson EB, Crane PK, Valladares O, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Scheff SW, Sonnen JA, Haines JL, Pericak-Vance MA, Mayeux R, Farrer LA, Van Eldik LJ, Horbinski C, Green RC, Gearing M, Poon LW, Kramer PL, Woltjer RL, Montine TJ, Partch AB, Rajic AJ, Richmire K, Monsell SE, , Schellenberg GD, Fardo DW
    Acta Neuropathol.
    2014 Jun
    127(6):825-43.
  8. Clinical-pathologic study of depressive symptoms and cognitive decline in old age.
    Wilson RS, Capuano AW, Boyle PA, Hoganson GM, Hizel LP, Shah RC, Nag S, Schneider JA, Arnold SE, Bennett DA
    Neurology
    2014 Jul 30
  9. Ex vivo T2 relaxation: associations with age-related neuropathology and cognition.
    Dawe RJ, Bennett DA, Schneider JA, Leurgans SE, Kotrotsou A, Boyle PA, Arfanakis K
    Neurobiol. Aging
    2014 Jul
    35(7):1549-61.
  10. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women.
    Bove R, Secor E, Chibnik LB, Barnes LL, Schneider JA, Bennett DA, De Jager PL
    Neurology
    2014 Jan 21
    82(3):222-9.
  11. Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates.
    Dugger BN, Clark CM, Serrano G, Mariner M, Bedell BJ, Coleman RE, Doraiswamy PM, Lu M, Fleisher AS, Reiman EM, Sabbagh MN, Sadowsky CH, Schneider JA, Zehntner SP, Carpenter AP, Joshi AD, Mintun MA, Pontecorvo MJ, Skovronsky DM, Sue LI, Beach TG
    J. Neuropathol. Exp. Neurol.
    2014 Jan
    73(1):72-80.
  12. Cognitive and social lifestyle: links with neuropathology and cognition in late life.
    Bennett DA, Arnold SE, Valenzuela MJ, Brayne C, Schneider JA
    Acta Neuropathol.
    2014 Jan
    127(1):137-50.
  13. Brain tocopherols related to Alzheimer's disease neuropathology in humans.
    Morris MC, Schneider JA, Li H, Tangney CC, Nag S, Bennett DA, Honer WG, Barnes LL
    Alzheimers Dement
    2014 Feb 28
  14. Association of Parkinson disease risk loci with mild parkinsonian signs in older persons.
    Shulman JM, Yu L, Buchman AS, Evans DA, Schneider JA, Bennett DA, De Jager PL
    JAMA Neurol
    2014 Apr
    71(4):429-35.
  15. Outcome markers for clinical trials in cerebral amyloid angiopathy.
    Greenberg SM, Al-Shahi Salman R, Biessels GJ, van Buchem M, Cordonnier C, Lee JM, Montaner J, Schneider JA, Smith EE, Vernooij M, Werring DJ
    Lancet Neurol
    2014 Apr
    13(4):419-28.
  16. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline.
    Yu L, Boyle PA, Leurgans S, Schneider JA, Bennett DA
    Neurobiol. Aging
    2014 Apr
    35(4):819-26.
  17. Interaction of transactive response DNA binding protein 43 with nuclear factor ?B in mild cognitive impairment with episodic memory deficits.
    Ohta Y, Tremblay C, Schneider JA, Bennett DA, Calon F, Julien JP
    Acta Neuropathol Commun
    2014
    2(1):37.
  18. TDP-43 Pathology, Cognitive Decline, and Dementia in Old Age.
    Wilson RS, Yu L, Trojanowski JQ, Chen EY, Boyle PA, Bennett DA, Schneider JA
    JAMA Neurol
    2013 Sep 30
  19. A 2-process model for neuropathology of Alzheimer's disease.
    Mungas D, Tractenberg R, Schneider JA, Crane PK, Bennett DA
    Neurobiol. Aging
    2013 Sep 27
  20. Modification of the Relationship of the Apolipoprotein E e4 Allele to the Risk of Alzheimer Disease and Neurofibrillary Tangle Density by Sleep.
    Lim AS, Yu L, Kowgier M, Schneider JA, Buchman AS, Bennett DA
    JAMA Neurol
    2013 Oct 21
  21. Resilient Brain Aging: Characterization of Discordance between Alzheimer's Disease Pathology and Cognition.
    Negash S, Wilson RS, Leurgans SE, Wolk DA, Schneider JA, Buchman AS, Bennett DA, Arnold SE
    Curr Alzheimer Res
    2013 Oct
    10(8):844-851.
  22. Elevated Aß42 in Aged, Non-demented Individuals with Cerebral Atherosclerosis.
    Sadleir KR, Bennett DA, Schneider JA, Vassar R
    Curr Alzheimer Res
    2013 Oct
    10(8):785-789.
  23. APOE e4, Alzheimer's Disease Pathology, Cerebrovascular Disease, and Cognitive Change Over the Years Prior to Death.
    Yu L, Boyle P, Schneider JA, Segawa E, Wilson RS, Leurgans S, Bennett DA.
    Psychol Aging. 2013
    2013 May 6. [Epub ahead of print]
  24. Association of brain pathology with the progression of frailty in older adults.
    Buchman AS, Yu L, Wilson RS, Schneider JA, Bennett DA.
    Neurology. 2013
    2013 May 28
    80(22):2055-61. doi: 10.1212/WNL.0b013e318294b462. Epub 2013 May 1.
  25. Brain amyloid-ß oligomers in ageing and Alzheimer's disease.
    Lesné SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, Bennett DA, Ashe KH.
    Brain. 2013
    2013 May
    136(Pt 5):1383-98. doi: 10.1093/brain/awt062. Epub 2013 Apr 9.
  26. Neural reserve, neuronal density in the locus ceruleus, and cognitive decline.
    Wilson RS, Nag S, Boyle PA, Hizel LP, Yu L, Buchman AS, Schneider JA, Bennett DA.
    Neurology. 2013
    2013 Mar 26
    80(13):1202-8. doi: 10.1212/WNL.0b013e3182897103. Epub 2013 Mar 13.
  27. Virological and Immunological Characteristics of Human Cytomegalovirus Infection Associated With Alzheimer Disease.
    Lurain NS, Hanson BA, Martinson J, Leurgans SE, Landay AL, Bennett DA, Schneider JA.
    J Infect Dis. 2013
    2013 Jun 5. [Epub ahead of print]
  28. Much of late life cognitive decline is not due to common neurodegenerative pathologies.
    Boyle PA, Wilson RS, Yu L, Barr AM, Honer WG, Schneider JA, Bennett DA.
    Ann Neurol. 2013
    2013 Jun 24. doi: 10.1002/ana.23964. [Epub ahead of print]
  29. Genetic Susceptibility for Alzheimer Disease Neuritic Plaque Pathology.
    Shulman JM, Chen K, Keenan BT, Chibnik LB, Fleisher A, Thiyyagura P, Roontiva A, McCabe C, Patsopoulos NA, Corneveaux JJ, Yu L, Huentelman MJ, Evans DA, Schneider JA, Reiman EM, De Jager PL, Bennett DA.
    JAMA Neurol. 2013
    2013 Jul 8:1-7. doi: 10.1001/jamaneurol.2013.2815. [Epub ahead of print]
  30. Life-span cognitive activity, neuropathologic burden, and cognitive aging.
    Wilson RS, Boyle PA, Yu L, Barnes LL, Schneider JA, Bennett DA.
    Neurology. 2013
    2013 Jul 3. [Epub ahead of print]
  31. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology.
    Bradshaw EM, Chibnik LB, Keenan BT, Ottoboni L, Raj T, Tang A, Rosenkrantz LL, Imboywa S, Lee M, Von Korff A; Alzheimer Disease Neuroimaging Initiative, Morris MC, Evans DA, Johnson K, Sperling RA, Schneider JA, Bennett DA, De Jager PL.
    Nat Neurosci. 2013
    2013 Jul
    16(7):848-50. doi: 10.1038/nn.3435. Epub 2013 May 23.
  32. Selected findings from the religious orders study and rush memory and aging project.
    Bennett DA, Wilson RS, Arvanitakis Z, Boyle PA, de Toledo-Morrell L, Schneider JA.
    J Alzheimers Dis. 2013
    2013 Jan 1
    33(0):S397-403. doi: 10.3233/JAD-2012-129007.
  33. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease.
    Arnold SE, Louneva N, Cao K, Wang LS, Han LY, Wolk DA, Negash S, Leurgans SE, Schneider JA, Buchman AS, Wilson RS, Bennett DA.
    Neurobiol Aging. 2013
    2013 Jan
    34(1):157-68. doi: 10.1016/j.neurobiolaging.2012.03.004. Epub 2012 May 2.
  34. Ex vivo MR volumetry of human brain hemispheres.
    Kotrotsou A, Bennett DA, Schneider JA, Dawe RJ, Golak T, Leurgans SE, Yu L, Arfanakis K.
    Magn Reson Med. 2013
    2013 Feb 25. doi: 10.1002/mrm.24661. [Epub ahead of print]
  35. Microvascular brain pathology and late-life motor impairment.
    Buchman AS, Yu L, Boyle PA, Levine SR, Nag S, Schneider JA, Bennett DA.
    Neurology. 2013
    2013 Feb 19
    80(8):712-8. doi: 10.1212/WNL.0b013e3182825116. Epub 2013 Jan 30.
  36. APOE e4 increases risk for dementia in pure synucleinopathies.
    Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, Irwin DJ, Rick J, Schellenberg GD, Watson GS, Kukull W, Nelson PT, Jicha GA, et al.
    JAMA Neurol. 2013
    2013 Feb
    70(2):223-8. doi: 10.1001/jamaneurol.2013.600.
  37. Acute Hemorrhagic Leukoencephalopathy Associated with Influenza A (H1N1) Virus.
    Jeganathan N, Fox M, Schneider J, Gurka D, Bleck T
    Neurocrit Care
    2013 Aug 14
  38. The PSEN1, p.E318G Variant Increases the Risk of Alzheimer's Disease in APOE-e4 Carriers.
    Benitez BA, Karch CM, Cai Y, Jin SC, Cooper B, Carrell D, Bertelsen S, Chibnik L, Schneider JA, Bennett DA, , , Fagan AM, Holtzman D, Morris JC, Goate AM, Cruchaga C
    PLoS Genet.
    2013 Aug
    9(8):e1003685.
  39. Estimating cerebral microinfarct burden from autopsy samples.
    Westover MB, Bianchi MT, Yang C, Schneider JA, Greenberg SM.
    Neurology. 2013
    2013 Apr 9
    80(15):1365-9. doi: 10.1212/WNL.0b013e31828c2f52. Epub 2013 Mar 13.
  40. Relation of neuropathology with cognitive decline among older persons without dementia.
    Boyle PA, Yu L, Wilson RS, Schneider JA, Bennett DA
    Front Aging Neurosci
    2013
    5:50.
  41. Effects of developmental lead exposure on the hippocampal transcriptome: influences of sex, developmental period, and lead exposure level.
    Schneider JS, Anderson DW, Talsania K, Mettil W, Vadigepalli R.
    Toxicol Sci. 2012
    2012 Sep
    129(1):108-25. doi: 10.1093/toxsci/kfs189. Epub 2012 May 28.
  42. Emotional neglect in childhood and cerebral infarction in older age.
    Wilson RS, Boyle PA, Levine SR, Yu L, Anagnos SE, Buchman AS, Schneider JA, Bennett DA.
    Neurology. 2012
    2012 Oct 9
    79(15):1534-9. doi: 10.1212/WNL.0b013e31826e25bd. Epub 2012 Sep 19.
  43. Antiphospholipid Antibodies, Brain Infarcts, and Cognitive and Motor Decline in Aging (ABICMA): Design of a Community-Based, Longitudinal, Clinical-Pathological Study.
    Arvanitakis Z, Brey RL, Rand JH, Schneider JA, Leurgans SE, Yu L, Buchman AS, Arfanakis K, Fleischman DA, Boyle PA, Bennett DA, Levine SR.
    Neuroepidemiology. 2012
    2012 Oct 24
    40(2):73-84. [Epub ahead of print]
  44. Molecular mechanisms of cortical degeneration in Parkinson disease.
    Shulman JM, Schneider JA.
    Neurology. 2012
    2012 Oct 23
    79(17):1750-1. doi: 10.1212/WNL.0b013e31827040c6. Epub 2012 Sep 26. No abstract available.
  45. Relation of neuropathology to cognition in persons without cognitive impairment.
    Bennett DA, Wilson RS, Boyle PA, Buchman AS, Schneider JA.
    Ann Neurol. 2012
    2012 Oct
    72(4):599-609. doi: 10.1002/ana.23654.
  46. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.
    Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Trojanowski JQ, Schellenberg GD, Yearout D, Huston H, et al.
    Neurology. 2012
    2012 Nov 6
    79(19):1944-50. doi: 10.1212/WNL.0b013e3182735e9a. Epub 2012 Oct 3.
  47. The complex PrP(c)-Fyn couples human oligomeric Aß with pathological tau changes in Alzheimer's disease.
    Larson M, Sherman MA, Amar F, Nuvolone M, Schneider JA, Bennett DA, Aguzzi A, Lesné SE.
    J Neurosci. 2012
    2012 Nov 21
    32(47):16857-71a. doi: 10.1523/JNEUROSCI.1858-12.2012.
  48. Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease.
    Buchman AS, Nag S, Shulman JM, Lim AS, VanderHorst VG, Leurgans SE, Schneider JA, Bennett DA.
    Mov Disord. 2012
    2012 Nov
    27(13):1625-31. doi: 10.1002/mds.25142. Epub 2012 Oct 4.
  49. Dementia from Alzheimer disease and mixed pathologies in the oldest old.
    James BD, Bennett DA, Boyle PA, Leurgans S, Schneider JA.
    JAMA. 2012
    2012 May 2
    307(17):1798-800. doi: 10.1001/jama.2012.3556. No abstract available.
  50. Effect of purpose in life on the relation between Alzheimer disease pathologic changes on cognitive function in advanced age.
    Boyle PA, Buchman AS, Wilson RS, Yu L, Schneider JA, Bennett DA.
    Arch Gen Psychiatry. 2012
    2012 May
    69(5):499-505. doi: 10.1001/archgenpsychiatry.2011.1487.
  51. Antemortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies.
    Kantarci K, Yang C, Schneider JA, Senjem ML, Reyes DA, Lowe VJ, Barnes LL, Aggarwal NT, Bennett DA, Smith GE, Petersen RC, Jack CR Jr, Boeve BF.
    Neurobiol Aging. 2012
    2012 May
    33(5):878-85. doi: 10.1016/j.neurobiolaging.2010.08.007. Epub 2010 Oct 18.
  52. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.
    Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kövari E, Kukull WA, Leverenz JB, et al.
    J Neuropathol Exp Neurol. 2012
    2012 May
    71(5):362-81. doi: 10.1097/NEN.0b013e31825018f7. Review.
  53. Cerebral microinfarcts: the invisible lesions.
    Smith EE, Schneider JA, Wardlaw JM, Greenberg SM.
    Lancet Neurol. 2012
    2012 Mar
    11(3):272-82. doi: 10.1016/S1474-4422(11)70307-6. Review.
  54. Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology.
    Larson ME, Sherman MA, Greimel S, Kuskowski M, Schneider JA, Bennett DA, Lesné SE.
    J Neurosci. 2012
    2012 Jul 25
    32(30):10253-66. doi: 10.1523/JNEUROSCI.0581-12.2012.
  55. The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementia.
    Barnes LL, Shah RC, Aggarwal NT, Bennett DA, Schneider JA.
    Curr Alzheimer Res. 2012
    2012 Jul
    9(6):734-45.
  56. Overview and findings from the rush Memory and Aging Project.
    Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS.
    Curr Alzheimer Res. 2012
    2012 Jul
    9(6):646-63.
  57. Overview and findings from the religious orders study.
    Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS.
    Curr Alzheimer Res. 2012
    2012 Jul
    9(6):628-45.
  58. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.
    Choi SR, Schneider JA, Bennett DA, Beach TG, Bedell BJ, Zehntner SP, Krautkramer MJ, Kung HF, Skovronsky DM, Hefti F, Clark CM.
    Alzheimer Dis Assoc Disord. 2012
    2012 Jan
    26(1):8-16. doi: 10.1097/WAD.0b013e31821300bc.
  59. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach.
    Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT; National Institute on Aging; Alzheimer’s Association.
    Acta Neuropathol. 2012
    2012 Jan
    123(1):1-11. doi: 10.1007/s00401-011-0910-3. Epub 2011 Nov 20.
  60. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.
    Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ.
    Alzheimers Dement. 2012
    2012 Jan
    8(1):1-13. doi: 10.1016/j.jalz.2011.10.007.
  61. Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy.
    Desai Bradaric B, Patel A, Schneider JA, Carvey PM, Hendey B.
    J Neural Transm. 2012
    2012 Jan
    119(1):59-71. doi: 10.1007/s00702-011-0684-8. Epub 2011 Jul 12.
  62. Nigral pathology and parkinsonian signs in elders without Parkinson disease.
    Buchman AS, Shulman JM, Nag S, Leurgans SE, Arnold SE, Morris MC, Schneider JA, Bennett DA.
    Ann Neurol. 2012
    2012 Feb
    71(2):258-66. doi: 10.1002/ana.22588.
  63. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.
    Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, Fleisher AS, Reiman EM, Sabbagh MN, Sadowsky CH, Schneider JA, Arora A, Carpenter AP, Flitter ML, Joshi AD, Krautkramer MJ, Lu M, Mintun MA, Skovronsky DM; AV-45-A16 Study Group.
    Lancet Neurol. 2012
    2012 Aug
    11(8):669-78. Epub 2012 Jun 28. Erratum in: Lancet Neurol. 2012 Aug;11(8):658.
  64. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
    Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE.
    J Clin Invest. 2012
    2012 Apr 2
    122(4):1316-38. doi: 10.1172/JCI59903.
  65. The CETP I405V polymorphism is associated with an increased risk of Alzheimer's disease.
    Yu L, Shulman JM, Chibnik L, Leurgans S, Schneider JA, De Jager PL, Bennett DA.
    Aging Cell. 2012
    2012 Apr
    11(2):228-33. doi: 10.1111/j.1474-9726.2011.00777.x. Epub 2011 Dec 29.
  66. Characteristics of MR infarcts associated with dementia and cognitive function in the elderly.
    Aggarwal NT, Schneider JA, Wilson RS, Beck TL, Evans DA, Carli CD.
    Neuroepidemiology. 2012
    2012
    38(1):41-7. doi: 10.1159/000334438. Epub 2011 Dec 17.
  67. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease.
    Cunnane SC, Schneider JA, Tangney C, Tremblay-Mercier J, Fortier M, Bennett DA, Morris MC.
    J Alzheimers Dis. 2012
    2012
    29(3):691-7. doi: 10.3233/JAD-2012-110629.
  68. Association of lower hemoglobin level and neuropathology in community-dwelling older persons.
    Shah RC, Schneider JA, Leurgans S, Bennett DA.
    J Alzheimers Dis. 2012
    2012
    32(3):579-86. doi: 10.3233/JAD-2012-120952.
  69. Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease.
    Tremblay C, St-Amour I, Schneider J, Bennett DA, Calon F.
    J Neuropathol Exp Neurol. 2011
    2011 Sep
    70(9):788-98. doi: 10.1097/NEN.0b013e31822c62cf.
  70. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.
    Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S; et al.
    Stroke. 2011
    2011 Sep
    42(9):2672-713. doi: 10.1161/STR.0b013e3182299496. Epub 2011 Jul 21. Review.
  71. Cerebrovascular disease pathology and parkinsonian signs in old age.
    Buchman AS, Leurgans SE, Nag S, Bennett DA, Schneider JA.
    Stroke. 2011
    2011 Nov
    42(11):3183-9. doi: 10.1161/STROKEAHA.111.623462. Epub 2011 Sep 1.
  72. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
    Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, et al.
    Nat Genet. 2011
    2011 May
    43(5):436-41. doi: 10.1038/ng.801. Epub 2011 Apr 3.
  73. Lewy bodies and olfactory dysfunction in old age.
    Wilson RS, Yu L, Schneider JA, Arnold SE, Buchman AS, Bennett DA.
    Chem Senses. 2011
    2011 May
    36(4):367-73. doi: 10.1093/chemse/bjq139. Epub 2011 Jan 21.
  74. Microinfarct pathology, dementia, and cognitive systems.
    Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA.
    Stroke. 2011
    2011 Mar
    42(3):722-7. doi: 10.1161/STROKEAHA.110.595082. Epub 2011 Jan 6.
  75. CR1 is associated with amyloid plaque burden and age-related cognitive decline.
    Chibnik LB, Shulman JM, Leurgans SE, Schneider JA, Wilson RS, Tran D, Aubin C, Buchman AS, Heward CB, Myers AJ, Hardy JA, Huentelman MJ, Corneveaux JJ, Reiman EM, Evans DA, Bennett DA, De Jager PL.
    Ann Neurol. 2011
    2011 Mar
    69(3):560-9. doi: 10.1002/ana.22277. Epub 2011 Mar 9.
  76. Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults.
    Dowling NM, Tomaszewski Farias S, Reed BR, Sonnen JA, Strauss ME, Schneider JA, Bennett DA, Mungas D.
    J Int Neuropsychol Soc. 2011
    2011 Jul
    17(4):602-14.
  77. Cognitive activities during adulthood are more important than education in building reserve.
    Reed BR, Dowling M, Tomaszewski Farias S, Sonnen J, Strauss M, Schneider JA, Bennett DA, Mungas D.
    J Int Neuropsychol Soc. 2011
    2011 Jul
    17(4):615-24. doi: 10.1017/S1355617711000014.
  78. Use of florbetapir-PET for imaging beta-amyloid pathology.
    Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, Pontecorvo MJ, Hefti F, Carpenter AP, Flitter ML, Krautkramer MJ, Kung HF, Coleman RE, Doraiswamy PM, Fleisher AS, Sabbagh MN, Sadowsky CH, Reiman EP, Zehntner SP, Skovronsky DM; AV45-A07 Study Group.
    JAMA. 2011
    2011 Jan 19
    305(3):275-83. doi: 10.1001/jama.2010.2008. Erratum in: JAMA. 2011 Mar 16;305(11):1096. Reiman, P Eric M [corrected to Reiman, Eric M].
  79. Functional screening of Alzheimer pathology genome-wide association signals in Drosophila.
    Shulman JM, Chipendo P, Chibnik LB, Aubin C, Tran D, Keenan BT, Kramer PL, Schneider JA, Bennett DA, Feany MB, De Jager PL.
    Am J Hum Genet. 2011
    2011 Feb 11
    88(2):232-8. doi: 10.1016/j.ajhg.2011.01.006. Epub 2011 Feb 3.
  80. Cerebral amyloid angiopathy pathology and cognitive domains in older persons.
    Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA.
    Ann Neurol. 2011
    2011 Feb
    69(2):320-7. doi: 10.1002/ana.22112. Epub 2010 Nov 8.
  81. Combinations of motor measures more strongly predict adverse health outcomes in old age: the rush memory and aging project, a community-based cohort study.
    Buchman AS, Leurgans SE, Boyle PA, Schneider JA, Arnold SE, Bennett DA.
    BMC Med. 2011
    2011 Apr 20
    9:42. doi: 10.1186/1741-7015-9-42.
  82. Vulnerability to stress, anxiety, and development of dementia in old age.
    Wilson RS, Begeny CT, Boyle PA, Schneider JA, Bennett DA.
    Am J Geriatr Psychiatry. 2011
    2011 Apr
    19(4):327-34. doi: 10.1097/JGP.0b013e31820119da.
  83. Analysis of postmortem ventricular cerebrospinal fluid from patients with and without dementia indicates association of vitamin E with neuritic plaques and specific measures of cognitive performance.
    Hensley K, Barnes LL, Christov A, Tangney C, Honer WG, Schneider JA, Bennett DA, Morris MC.
    J Alzheimers Dis. 2011
    2011
    24(4):767-74. doi: 10.3233/JAD-2011-101995.
  84. Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study.
    Dawe RJ, Bennett DA, Schneider JA, Arfanakis K.
    PLoS One. 2011
    2011
    6(10):e26286. doi: 10.1371/journal.pone.0026286. Epub 2011 Oct 17.
  85. Neurodegenerative basis of age-related cognitive decline
    Wilson RS, Leurgans SE, Boyle PA, Schneider JA, Bennett DA
    Neurology
    2010 Sep 21
    75(12):1070-8
  86. Where vascular meets neurodegenerative disease.
    Schneider JA, Bennett DA.
    Stroke. 2010
    2010 Oct
    41(10 Suppl):S144-6. doi: 10.1161/STROKEAHA.110.598326.
  87. Cerebral amyloid angiopathy pathology and cognitive domains in older persons
    Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA
    Ann Neurol
    2010 Nov 8
  88. Increasing incidence of dementia in the oldest old: evidence and implications.
    James BD, Schneider JA.
    Alzheimers Res Ther. 2010
    2010 May 13
    2(3):9. doi: 10.1186/alzrt32.
  89. Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans.
    Soetanto A, Wilson RS, Talbot K, Un A, Schneider JA, Sobiesk M, Kelly J, Leurgans S, Bennett DA, Arnold SE.
    Arch Gen Psychiatry. 2010
    2010 May
    67(5):448-57. doi: 10.1001/archgenpsychiatry.2010.48.
  90. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.
    Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DM, Pickering-Brown SM, Seelaar H, Heutink P, van Swieten JC, Murrell JR, Ghetti B, Spina S, Grafman J, Hodges J, Spillantini MG, et al.
    Nat Genet. 2010
    2010 Mar
    42(3):234-9. doi: 10.1038/ng.536. Epub 2010 Feb 14.
  91. Intermediate phenotypes identify divergent pathways to Alzheimer's disease.
    Shulman JM, Chibnik LB, Aubin C, Schneider JA, Bennett DA, De Jager PL.
    PLoS One. 2010
    2010 Jun 21
    5(6):e11244. doi: 10.1371/journal.pone.0011244.
  92. High blood pressure and microinfarcts: a link between vascular risk factors, dementia, and clinical Alzheimer's disease.
    Schneider JA.
    J Am Geriatr Soc. 2009
    2009 Nov
    57(11):2146-7. doi: 10.1111/j.1532-5415.2009.02521.x. No abstract available.
  93. Evidence of angiogenic vessels in Alzheimer's disease.
    Desai BS, Schneider JA, Li JL, Carvey PM, Hendey B.
    J Neural Transm. 2009
    2009 May
    116(5):587-97. doi: 10.1007/s00702-009-0226-9. Epub 2009 Apr 16.
  94. Olfactory impairment in presymptomatic Alzheimer's disease.
    Wilson RS, Arnold SE, Schneider JA, Boyle PA, Buchman AS, Bennett DA.
    Ann N Y Acad Sci. 2009
    2009 Jul
    1170:730-5. doi: 10.1111/j.1749-6632.2009.04013.x.
  95. The neuropathology of probable Alzheimer disease and mild cognitive impairment.
    Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA.
    Ann Neurol. 2009
    2009 Aug
    66(2):200-8. doi: 10.1002/ana.21706.
  96. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles.
    Bennett DA, De Jager PL, Leurgans SE, Schneider JA.
    Neurology. 2009
    2009 Apr 28
    72(17):1495-503. doi: 10.1212/WNL.0b013e3181a2e87d.
  97. Postmortem MRI of human brain hemispheres: T2 relaxation times during formaldehyde fixation.
    Dawe RJ, Bennett DA, Schneider JA, Vasireddi SK, Arfanakis K.
    Magn Reson Med. 2009
    2009 Apr
    61(4):810-8. doi: 10.1002/mrm.21909.
  98. The neuropathology of older persons with and without dementia from community versus clinic cohorts.
    Schneider JA, Aggarwal NT, Barnes L, Boyle P, Bennett DA.
    J Alzheimers Dis. 2009
    2009
    18(3):691-701. doi: 10.3233/JAD-2009-1227.
  99. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology
    Arvanitakis Z, Schneider JA, Wilson RS, Bienias JL, Kelly JF, Evans DA, Bennett DA
    Neurology
    2008 May 6
    70(19 Pt 2):1795-802
  100. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology
    Arvanitakis Z, Grodstein F, Bienias JL, Schneider JA, Wilson RS, Kelly JF, Evans DA, Bennett DA
    Neurology
    2008 Jun 3
    70(23):2219-25
  101. Levels of estrogen receptors alpha and beta in frontal cortex of patients with Alzheimer's disease: relationship to Mini-Mental State Examination scores.
    Kelly JF, Bienias JL, Shah A, Meeke KA, Schneider JA, Soriano E, Bennett DA.
    Curr Alzheimer Res. 2008
    2008 Feb
    5(1):45-51.
  102. Cognitive performance correlates with cortical isopeptide immunoreactivity as well as Alzheimer type pathology.
    Wang DS, Uchikado H, Bennett DA, Schneider JA, Mufson EJ, Wu J, Dickson DW.
    J Alzheimers Dis. 2008
    2008 Feb
    13(1):53-66.
  103. Physical frailty in older persons is associated with Alzheimer disease pathology.
    Buchman AS, Schneider JA, Leurgans S, Bennett DA.
    Neurology. 2008
    2008 Aug 12
    71(7):499-504. doi: 10.1212/01.wnl.0000324864.81179.6a.
  104. Processing resources reduce the effect of Alzheimer pathology on other cognitive systems
    Boyle PA, Wilson RS, Schneider JA, Bienias JL, Bennett DA
    Neurology
    2008 Apr 22
    70(17):1534-42